Gland Pharma share price: The counter's 14-day relative strength index (RSI) came at 16.61. A level below 30 is defined as oversold while a value above 70 is considered overbought. The company's stock has a price-to-equity (P/E) ratio of 22.73. It has a price-to-book (P/B) value of 2.22.
Gland Pharma shares plummeted nearly 20% on Monday, taking its two-day fall to 34%. Watch this Visual Story to see if you should buy the dip in Gland Pharma share price.
Gland Pharma share price: The counter's 14-day relative strength index (RSI) came at 70.61. A level below 30 is defined as oversold while a value above 70 is considered overbought. The company's stock has a price-to-equity (P/E) ratio of 20.64. It has a price-to-book (P/B) value of 2.65.
Gland Pharma share hit a fresh all-time high today after the firm said it inked a deal with Russian Direct Investment Fund (RDIF) to manufacture and supply up to 252 million doses of Russia s Sputnik V coronavirus vaccine. The production will begin in the